Stocks
Emergent BioSolutions Inc.EBS
NYSEHealthcareBiotechnology$8.07-0.68%
A developer and manufacturer of vaccines and antibody-based therapies focused on public health threats, including biodefense and infectious diseases. Its products and contract manufacturing services support government stockpiles and preparedness programs, with significant revenue tied to U.S. federa...
Market Cap: $423.8M52W Range: $4.02 – $14.06
Congressional Interest in Emergent BioSolutions Inc. (EBS)
8 members of Congress have disclosed 19 trades in Emergent BioSolutions Inc. (EBS), a Healthcare company. The buy/sell breakdown shows 10 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
8
Buys
10
Sells
9
Who in Congress Is Trading EBS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-12-11 | STEVE COHEN | sell | $1K – $15K |
| 2023-06-29 | Rohit Khanna | buy | $1K – $15K |